- Published at
- by prnewswire.com
mixed
mixed
Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, & Lipoglycopeptide
/PRNewswire/ -- The
News for Innovation Pharmaceuticals Inc. (IPIX)
- Published at
- by globenewswire.com
positivepositiveInnovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases
WAKEFIELD, MA, June 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage...- Published at
- by globenewswire.com
positivepositiveInnovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing
WAKEFIELD, MA, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage...- Published at
- by globenewswire.com
neutralneutralInnovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers
WAKEFIELD, MA, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage...- Published at
- by globenewswire.com
positivepositiveInnovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement
Multiyear Development and Support Agreement Lays the Foundation for the Realization of an Advanced Software Suite to Enable Revolutionary Treatments of...- Published at
- by globenewswire.com
neutralneutralInnovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis
Additionally, Brilacidin to be Screened by NIH/NIAID to Further Characterize Its Broad-Spectrum Antifungal Activity WAKEFIELD, MA, Dec. 13, 2022 (GLOBE...- Published at
- by globenewswire.com
mixedmixedInnovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family
Regulatory clearance lays key technological and regulatory foundation for BT BeaMedical’s vision of revolutionizing treatment options in neurosurgery,...- Published at
- by prnewswire.com
mixedmixedGlobal COVID-19 Therapeutics Market worth $14.6 billion by 2022 - Exclusive Report by InsightAce Analytic
/PRNewswire/ -- The newly published report titled "Global COVID-19 Therapeutics Market– By Trends, Industry Competition Analysis, Clinical Trial/Pipeline...- Published at
- by marketscreener.com
neutralneutralInnovation Pharmaceuticals : OTCQB Certification
OTCQB Certification I, Leo Ehrlich, CEOof Innovation Pharmacuticals Inc., certify that: 1. The Company is registered or required to file... | December 24, 2021- Published at
- by thestreet.com
mixedmixedLightbridge Corporation Expands Board Of Directors With Appointment Of Two Independent Directors
RESTON, Va., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced today that it